Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹171.06
2.91 (1.73%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹5.02K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
35.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹67.19+154.6%
52W High₹177.9-3.8%
Current Price
₹171.06
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹136.85
Upper Circuit₹205.27
Reference Price
₹171.06
Investment Checklist
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 52.62 (BUY) with 54.3% confidence
RSI at 77.0 — overbought, pullback risk
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
News: Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why...
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
54%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
146.53
EMA50
129.02
EMA200
104.25
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows7
Lower Highs4
Lower Lows2
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹139.43
₹126.66
₹123.20
₹116.46
₹106.00
Volume Analysis
TrendINCREASING
Change+307.50%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹169.35
3% Risk₹165.93
5% Risk₹162.51
7% Risk (Custom)
₹159.09Technical Levels
1x ATR (Volatility)₹161.42
2x ATR (Swing)₹151.78
3x ATR (Trend)₹142.14
Immediate Support₹139.43
Moving Averages
EMA 9 (Short-term)₹157.42
EMA 20 (Medium-term)₹146.53
EMA 50 (Trend)₹129.02
EMA 200 (Long-term)₹104.25
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹516.8 Cr | ₹551.7 Cr | ₹567.5 Cr | ₹580.4 Cr |
| Net Profit | ₹31.4 Cr | ₹33.9 Cr | ₹30 Cr | ₹20.6 Cr |
| EPS | — | ₹1.16 | ₹1.02 | ₹0.70 |
| Operating Profit | ₹62.4 Cr | ₹69.5 Cr | ₹64 Cr | ₹51.4 Cr |
ROE
5.99%
ROCE
8.19%
Debt/Equity
0.07
Current Ratio
1.89
OPM
8.85%
NPM
3.55%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| IOL Chemicals and Pharmaceuticals Limited | ₹171.06 | +1.73% | 35.9 | ₹5.02K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 17 Feb 2026 | Interim Dividend - Re 1 Per Share | INTERIM_DIVIDEND |
| 11 Mar 2025 | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share | STOCK_SPLIT |
| 18 Feb 2025 | Interim Dividend - Rs 4 Per Share | INTERIM_DIVIDEND |
| 16 Aug 2024 | Annual General Meeting | AGM |
| 16 Feb 2024 | Interim Dividend - Rs 5 Per Share | INTERIM_DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for IOLCP
View All
positive
Business Standard - Markets 3d ago
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.
ABGSECABSL10BANKABSLAMCABSLBANETFABSLLIQUIDABSLNN50ETABSLPSEACUTAASALIVUSBSLGOLDETFBSLNIFTYBSLSENETFGGSEC10ABSLHEALTHYHIKALIOLCPJFLLIFEJFL-REJGCHEMLUPINMOMENTUMNIFTYQLITYORCHPHARMARPGLIFESAILIFESILVERSOLARASPARCSUVENTECHChemicalsFinancial Services
NEWS
positive
Business Standard - Markets 3d ago
J B Chemicals & Pharmaceuticals Ltd up for fifth session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2419.6, up 1.24% on the day as on 12:44 IST on the NSE. The stock is up 48.86% in last one year as compared to a 4.11% spurt in NIFTY and a 16.43% spurt in the Nifty Pharma.
AONELIQUIDAONENIFTYAONETMMQ50AONETOTALBIOFILCHEMCHEMICALGROWWCHEMIOLCPJBCHEPHARMJGCHEMPHARMABEESChemicalsFinancial Services
positive
CNBC TV18 - Markets 3d ago
IOL Chemicals shares hit upper circuit after promoter raises stake in the June quarter
One of the key developments during the June quarter was an increase in promoter ownership. Promoter shareholding rose to 62.28% as of June 2026 from 57.48% at the end of March.
IOLCPJGCHEMChemicalsHealthcare